Gene-Modified Blister Fluid–Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa-Reference-Cited by-同舟云学术

Gene-Modified Blister Fluid–Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa

Published:2023-12 Issue:12 Volume:143 Page:2447-2455.e8
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Kikuchi Yasushi^ORCID,Tamakoshi Tomoki^ORCID,Ishida Ryuichi^ORCID,Kobayashi Ryosuke^ORCID,Mori Shiho^ORCID,Ishida-Yamamoto Akemi^ORCID,Fujimoto Manabu^ORCID,Kaneda Yasufumi^ORCID,Tamai Katsuto^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference35 articles.

1. Pro-inflammatory chemokines and cytokines dominate the blister fluid molecular signature in patients with epidermolysis bullosa and affect leukocyte and stem cell migration;Alexeev;J Invest Dermatol,2017

2. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa;Conget;Cytotherapy,2010

3. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement;Dominici;Cytotherapy,2006

4. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa;Eichstadt;JCI Insight,2019

5. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986–2006;Fine;J Am Acad Dermatol,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatment;Stem Cells Translational Medicine;2024-06-01

2. Emerging Strategies for Optimizing Cell‐Derived Decellularized Extracellular Matrix Scaffolds in Tissue Engineering;Advanced Engineering Materials;2024-04-09

3. Development of evolutionarily conserved viral integration sites as safe harbors for human gene therapy;2023-09-10